Magdelijns Fabienne J H, van den Beuken-van Everdingen Marieke H J, Courtens Annemie M, Janssen Daisy J A
Maastricht Universitair Medisch Centrum, afd. Interne Geneeskunde, Maastricht.
Ned Tijdschr Geneeskd. 2015;159:A8121.
Pain is common in patients with cancer (33-64%) and can be divided into background and breakthrough pain (BTP). BTP is a passing, acute pain that occurs despite the use of analgesia to control background pain. BTP may arise spontaneously or be provoked by certain movements or activities. It lasts 30-60 minutes and is generally self-limiting and is often undertreated. We describe 2 patients aged 68 and 57 years with metastatic disease who were admitted for pain management. BTP was inadequately managed during their hospital stay. Both patients had to wait too long before they received their BTP medication, causing the BTP to have passed its peak. After consultation with their nurses, both patients were allowed to have one dose of breakthrough medication in advance, which resulted in better treatment of their BTP. Every hospitalized patient with BTP should have one dose of breakthrough medication ready for taking in advance.
疼痛在癌症患者中很常见(33%-64%),可分为背景性疼痛和爆发性疼痛(BTP)。爆发性疼痛是一种短暂的急性疼痛,尽管使用了镇痛药物来控制背景性疼痛仍会发生。爆发性疼痛可能自发出现,也可能由某些动作或活动诱发。它持续30-60分钟,通常为自限性,且常常治疗不足。我们描述了2例分别为68岁和57岁的转移性疾病患者,他们因疼痛管理入院。在住院期间,他们的爆发性疼痛管理不当。两名患者都等了太长时间才得到爆发性疼痛药物,导致爆发性疼痛已过峰值。在与护士协商后,两名患者都被允许提前服用一剂突破性药物,这使得他们的爆发性疼痛得到了更好的治疗。每一位住院的爆发性疼痛患者都应该提前准备好一剂突破性药物以便服用。